Terremoto
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
230 E Grand Ave Ste 200, South San Franc...Phone Number
(415) 535-2787Website
www.terremotobio.comRevenue
$13.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Terremoto
Terremoto Biosciences is a biotechnology company focused on discovering and developing next-generation small-molecule therapies for cancer and other serious diseases. It uses advanced covalent chemistry and structure-based drug design to target disease-driving proteins, including previously undruggable targets. The company aims to create highly selective medicines with improved efficacy and safety to address areas of high unmet medical need.Explore more
Terremoto Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Terremoto your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Terremoto has recently received funding, and reach out quickly before it becomes old news!
Click to see if Terremoto had a recent Job posting/layoffs
Terremoto, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Terremoto
Product Launch: Get notified when Terremoto launches new products
Funding: Get notified immidiatlly once Terremoto has new funding data
Check out if Terremoto is spiking on competitors!
Earning: See what the market has to say on Terremoto recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Terremoto
Compare insights from companies similar to Terremoto, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Terremoto is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Terremoto is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Terremoto.
Terremoto financials insights
Gather financial insights about Terremoto, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$75M
2023
Series B
$175M
2026
Series C
$108M
Terremoto Tech Stack
A closer look at the technologies used by Terremoto
See more technologies
Most Recent Scoops
Open Position
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a mid-level source in product development, is in the midst of initiatives related to quality assurance. The organization is currently evaluating MasterControl QMS. Terremoto is expected to decrease workforce due to expected initiative efficiency gains. QA compliance is being included as a focus of these efforts.
Quality Assurance, Product Development, Product Management, Compliance
Project
Laboratory Operations, Medical Research, Clinical Operations
Terremoto News & Media
Terremoto makes strides with $108m Series C - BioXconomy
San Francisco-based Terremoto Biosceinces will use the financing to advance its lead programs in cancer and hereditary hemorrhagic telangiectasia.Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors - Fierce Biotech
Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to continue its efforts to broaden the covalent drug alphabet. | Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to continue its efforts to broaden the covalent drug alphabet.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Terremoto
Sign Up For FreeTo access detailed company insights
Terremoto Biosciences is a biotechnology company focused on discovering and developing next-generation small-molecule therapies for cancer and other serious diseases. It uses advanced covalent chemistry and structure-based drug design to target disease-driving proteins, including previously undruggable targets. The company aims to create highly sel... Read More
